|Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality|
N Ochs, R Auer, DC Bauer, D Nanchen, J Gussekloo, J Cornuz, ...
Annals of internal medicine 148 (11), 832-845, 2008
|Heat-not-burn tobacco cigarettes: smoke by any other name|
R Auer, N Concha-Lozano, I Jacot-Sadowski, J Cornuz, A Berthet
JAMA internal medicine 177 (7), 1050-1052, 2017
|Association of major and minor ECG abnormalities with coronary heart disease events|
R Auer, DC Bauer, P Marques-Vidal, J Butler, LJ Min, J Cornuz, ...
Jama 307 (14), 1497-1505, 2012
|Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes|
D Nanchen, B Gencer, R Auer, L Räber, GG Stefanini, R Klingenberg, ...
European heart journal 36 (36), 2438-2445, 2015
|Association between lifetime marijuana use and cognitive function in middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) study|
R Auer, E Vittinghoff, K Yaffe, A Künzi, SG Kertesz, DA Levine, ...
JAMA internal medicine 176 (3), 352-361, 2016
|Prognostic value of PCSK9 levels in patients with acute coronary syndromes|
B Gencer, F Montecucco, D Nanchen, F Carbone, R Klingenberg, ...
European Heart Journal 37 (6), 546-553, 2016
|Prognosis of patients with familial hypercholesterolemia after acute coronary syndromes|
D Nanchen, B Gencer, O Muller, R Auer, S Aghlmandi, D Heg, ...
Circulation 134 (10), 698-709, 2016
|Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis|
MJ Pletcher, M Pignone, S Earnshaw, C McDade, KA Phillips, R Auer, ...
Circulation: Cardiovascular Quality and Outcomes 7 (2), 276-284, 2014
|Subclinical thyroid dysfunction and cardiovascular outcomes among prospective cohort studies|
B Gencer, TH Collet, V Virgini, R Auer, N Rodondi
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2013
|Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline|
LM Helsingen, PO Vandvik, HC Jodal, T Agoritsas, L Lytvyn, JC Anderson, ...
Bmj 367, 2019
|Efficacy of in-hospital multidimensional interventions of secondary prevention after acute coronary syndrome: a systematic review and meta-analysis|
R Auer, J Gaume, N Rodondi, J Cornuz, WA Ghali
Circulation 117 (24), 3109-3117, 2008
|Cumulative lifetime marijuana use and incident cardiovascular disease in middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) study|
JP Reis, R Auer, MP Bancks, DC Goff Jr, CE Lewis, MJ Pletcher, JS Rana, ...
American journal of public health 107 (4), 601-606, 2017
|Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline|
KAO Tikkinen, P Dahm, L Lytvyn, AF Heen, RWM Vernooij, ...
Bmj 362, 2018
|Association between resistin levels and cardiovascular disease events in older adults: the health, aging and body composition study|
B Gencer, R Auer, N De Rekeneire, J Butler, A Kalogeropoulos, DC Bauer, ...
Atherosclerosis 245, 181-186, 2016
|Safety profile of prasugrel and clopidogrel in patients with acute coronary syndromes in Switzerland|
R Klingenberg, D Heg, L Räber, D Carballo, D Nanchen, B Gencer, ...
Heart 101 (11), 854-863, 2015
|Reasons for discontinuation of recommended therapies according to the patients after acute coronary syndromes|
B Gencer, N Rodondi, R Auer, L Räber, R Klingenberg, D Nanchen, ...
European journal of internal medicine 26 (1), 56-62, 2015
|Expected impact of applying new 2013 AHA/ACC cholesterol guidelines criteria on the recommended lipid target achievement after acute coronary syndromes|
B Gencer, R Auer, D Nanchen, L Räber, R Klingenberg, D Carballo, ...
Atherosclerosis 239 (1), 118-124, 2015
|Publication trends of shared decision making in 15 high impact medical journals: a full-text review with bibliometric analysis|
X Blanc, TH Collet, R Auer, R Fischer, I Locatelli, P Iriarte, J Krause, ...
BMC medical informatics and decision making 14 (1), 1-9, 2014
|Quality of care after acute coronary syndromes in a prospective cohort with reasons for non-prescription of recommended medications|
R Auer, B Gencer, L Räber, R Klingenberg, S Carballo, D Carballo, ...
PloS one 9 (3), e93147, 2014
|Eligibility for PCSK 9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines …|
B Gencer, KC Koskinas, L Räber, A Karagiannis, D Nanchen, R Auer, ...
Journal of the American Heart Association 6 (11), e006537, 2017